Efficacy and safety of pirarubicin plus capecitabine versus pirarubicin plus cyclophosphamide in Chinese node-negative breast cancer patients: a 4-year open-label, randomized, controlled study
Zhang, Xiaohui, Zhou, Yidong, Mao, Feng, Lin, Yan, Guan, Jinghong, Sun, QiangVolume:
32
Language:
english
Journal:
Medical Oncology
DOI:
10.1007/s12032-015-0686-8
Date:
October, 2015
File:
PDF, 641 KB
english, 2015